Novo Nordisk A/S - Share repurchase programme

July 02, 2012 08:33 ET | Source: Novo Nordisk A/S Novo Nordisk A/S

Attachments

Company announcement No 43 / 2012

Company announcement No 43 / 2012...

Recommended Reading

April 09, 2026 08:28 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU

Wegovy® injection is the first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
Read More
April 07, 2026 06:46 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 7 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Read More